US Stock MarketDetailed Quotes

KOD Kodiak Sciences

Watchlist
  • 3.190
  • -0.190-5.62%
Trading Apr 25 14:50 ET
167.59MMarket Cap-641P/E (TTM)

About Kodiak Sciences Company

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Company Profile

SymbolKOD
Company NameKodiak Sciences
Listing DateOct 4, 2018
Issue Price10.00
Founded2009
CEODr. Victor Perlroth, M.D.
MarketNASDAQ
Employees111
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1200 Page Mill Road
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94304
Phone1-650-281-0850
Websitehttp://www.kodiak.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Victor Perlroth, M.D.
  • Chief Executive Officer, President and Chairman of the Board
  • 113.37M
  • John A. Borgeson
  • Executive Vice President, Chief Financial Officer, Secretary and Principal Accounting Officer
  • 27.87M
  • Dr. Taiyin Yang, PhD
  • Independent Director
  • 440.32K
  • Dr. Richard S. Levy,M.D.
  • Independent Director
  • 436.07K
  • Dr. Felix J. Baker,PhD
  • Independent Director
  • 389.82K
  • Robert A. Profusek
  • Lead Independent Director
  • 471.07K
  • Charles A. Bancroft
  • Independent Director
  • 460.97K
  • Dr. Bassil I. Dahiyat, PhD.
  • Independent Director
  • 442.18K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg